Bay 65-1942 R form 10mg 10mg | Purity Not Available
Adooq Bioscience
Bay 65-1942 (R form) is an ATP-competitive inhibitor that selectively targets IKK?? kinase.
More Information Supplier PageBay 65-1942 (R form) is an ATP-competitive inhibitor that selectively targets IKK?? kinase.
More Information Supplier PageBAY 61-3606 is a potent (Ki = 7.5 nM) and selective inhibitor of Syk kinase.
More Information Supplier PageBAY 61-3606 is a potent (Ki = 7.5 nM) and selective inhibitor of Syk kinase.
More Information Supplier PageBAY 61-3606 is a potent (Ki = 7.5 nM) and selective inhibitor of Syk kinase.
More Information Supplier PageBavisant dihydrochloride hydrate is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.
More Information Supplier PageBavisant dihydrochloride hydrate is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.
More Information Supplier PageBavisant dihydrochloride hydrate is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.
More Information Supplier PageBavisant dihydrochloride is a highly selective, orally active antagonist of the human H3 receptor with a novel mechanism of action, involving wakefulness and cognition, with potential as a treatment for ADHD.
More Information Supplier PageBay 65-1942 (R form) is an ATP-competitive inhibitor that selectively targets IKK?? kinase.
More Information Supplier PageBazedoxifene is a third generation selective modulator of estrogen receptor.
More Information Supplier Page